GAMMA Investing’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Buy
4,796
+1,808
+61% +$671K 0.07% 233
2026
Q1
$875K Sell
2,988
-976
-25% -$321K 0.04% 379
2025
Q4
$1.39M Buy
3,964
+1,304
+49% +$441K 0.07% 227
2025
Q3
$859K Sell
2,660
-285
-10% -$88.6K 0.05% 337
2025
Q2
$1.15M Sell
2,945
-445
-13% -$179K 0.07% 242
2025
Q1
$1.47M Buy
3,390
+1,588
+88% +$637K 0.11% 166
2024
Q4
$665K Sell
1,802
-1,296
-42% -$542K 0.06% 295
2024
Q3
$1.61M Buy
3,098
+502
+19% +$268K 0.16% 114
2024
Q2
$1.41M Buy
2,596
+673
+35% +$356K 0.19% 91
2024
Q1
$997K Buy
1,923
+369
+24% +$184K 0.2% 82
2023
Q4
$767K Buy
+1,554
New +$719K 0.21% 76

Other funds holding ELV

GAMMA Investing's ELV Position: Q2 2026 in Review

GAMMA Investing increased its Elevance Health (ELV) stake by 61% in Q2 2026, buying an estimated $671K and bringing the position to 4,796 shares worth $1.85M. The position accounts for 0.07% of the portfolio, ranked #233.

GAMMA Investing first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • GAMMA Investing held 4,796 shares of Elevance Health worth $1.85M as of Q2 2026.
  • GAMMA Investing bought 1,808 Elevance Health shares in Q2 2026, an estimated $671K.
  • Elevance Health made up 0.07% of GAMMA Investing's portfolio in Q2 2026, its #233 holding.
  • GAMMA Investing first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.